Twist Bioscience Earnings
NASDAQ: TWSTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 159.74 -0.03%
Twist Bioscience earnings summary
In its most recent report on Aug 3, 2026 (Q3 2026), TWST posted EPS of $-0.56. Revenue for the quarter was $118.4 million. Quarterly EPS is down 269.7% from the same quarter a year earlier.
Across the last 16 reports, TWST shares moved an average of 7.2% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
TWST earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 3, 2026 | — | $-0.56 | — | +2.5% |
| May 4, 2026 | — | $-0.71 | — | -13.5% |
| Feb 2, 2026 | — | $-0.50 | — | -0.3% |
| Nov 17, 2025 | — | $-0.44 | — | +12.1% |
| Aug 4, 2025 | — | $0.33 | — | +9.7% |
| May 5, 2025 | — | $-0.66 | — | +0.4% |
| Feb 3, 2025 | — | $-0.53 | — | -9.0% |
| Nov 18, 2024 | — | $-0.59 | — | +16.5% |
| Aug 2, 2024 | — | $-1.47 | — | +2.3% |
| May 2, 2024 | — | $-0.79 | — | +2.8% |
| Feb 2, 2024 | — | $-0.75 | — | +4.4% |
| Nov 21, 2023 | — | $-0.81 | — | +1.2% |
| Aug 7, 2023 | — | $-1.01 | — | -12.8% |
| May 8, 2023 | — | $-1.04 | — | +9.0% |
| Feb 7, 2023 | — | $-0.74 | — | -5.0% |
| Nov 28, 2022 | — | $-0.92 | — | -14.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.